Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort

Early Intervention in Psychiatry

Volumn 4, Issue 3, 2010, Pages 220-226

  Cadenhead, Kristin S ^a   Addington, Jean ^b   Cannon, Tyrone ^c   Cornblatt, Barbara ^d   McGlashan, Thomas ^e   Perkins, Diana ^f   Seidman, Larry ^g   Tsuang, Ming ^a   Walker, Elaine ^h   Woods, Scott ^e   Heinssen, Robert ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Pharmacotherapy; Prodrome; Psychosis; Schizophrenia; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CENTRAL STIMULANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL DECISION MAKING; CLINICAL RESEARCH; DEMOGRAPHY; FAMILY THERAPY; FEMALE; GROUP THERAPY; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NORTH AMERICA; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; PSYCHOSIS; PSYCHOTHERAPY; SYMPTOM; SYNDROME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NORTH AMERICA; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 77955752796     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2010.00183.x     Document Type: Article

References (20)

1. Cannon TD, Cadenhead K, Cornblatt B. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008, 65(1):28-37.
2. Cornblatt BA, Lencz T, Smith CW. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 2007, 68(4):546-57.
3. McGlashan TH, Zipursky RB, Perkins D. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006, 163(5):790-9.
4. Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev 2006, 4:CD004718.
5. Morrison AP, French P, Walford L. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004, 185:291-7.
6. Addington J, Cadenhead KS, Cannon TD. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 2007, 3:665-72.
7. Hall RC, Parks J. The modified global assessment of functioning scale: addendum. Psychosomatics 1995, 36(4):416-7.
8. van Mastrigt S, Addington J. Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 2002, 27(2):92-101.
9. Cornblatt BA, Auther AM, Niendam T. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull 2007, 33(3):688-702.
10. Miller TJ, McGlashan TH, Rosen JL. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003, 29(4):703-15.
11. Ballon JS, Kaur T, Marks II. Social functioning in young people at risk for schizophrenia. Psychiatry Res 2007, 151:29-35.
12. Cornblatt BA, Lencz T, Kane JM. Treatment of the schizophrenia prodrome: is it presently ethical? Schizophr Res 2001, 51(1):31-8.
13. Corcoran C, Malaspina D, Hercher L. Prodromal interventions for schizophrenia vulnerability: the risks of being 'at risk'. Schizophr Res 2005, 73(2-3):173-84.
14. Falloon IR, Coverdale JH, Laidlaw TM. Early intervention for schizophrenic disorders. Implementing optimal treatment strategies in routine clinical services. OTP Collaborative Group. Br J Psychiatry 1998, 172(1):33-8. Suppl
15. McGlashan TH. Psychosis treatment prior to psychosis onset: ethical issues. Schizophr Res 2001, 51(1):47-54.
16. McGorry PD, Yung AR, Phillips LJ. The 'close-in' or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 2003, 29(4):771-90.
17. Perkins DO. Evaluating and treating the prodromal stage of schizophrenia. Curr Psychiatry Rep 2004, 6(4):289-95.
18. Haroun N, Dunn L, Haroun A. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006, 32(1):166-78.
19. McGorry PD, Hickie IB, Yung AR. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006, 40(8):616-22.
20. Yung AR, Yuen HP, Berger G. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007, 33(3):673-81.